Lord, Abbett & Co
INFI

Lord, Abbett & Co’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Lord, Abbett & Co’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-326,054
Closed -$5.51M – 967
2014
Q4 		$5.51M Buy
326,054
+4,090
+1% +$59.6K 0.01% 713
2014
Q3 		$4.32M Buy
+321,964
New +$3.83M 0.01% 771

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co's INFI Position: Q1 2015 in Review

Lord, Abbett & Co sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 326,054 shares — an estimated $5.51M sold.

Lord, Abbett & Co first reported a position in INFI in Q3 2014 and held it in 2 quarters. The position peaked at $5.51M in Q4 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Lord, Abbett & Co reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 326,054 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $5.51M.
  • Lord, Abbett & Co first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 2 quarters.
  • Lord, Abbett & Co's Infinity Pharmaceuticals, Inc. position peaked at $5.51M in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Lord, Abbett & Co's 13F filing for Q1 2015, filed 15 May 2015.